148 related articles for article (PubMed ID: 15383705)
41. Interaction of streptolysin-O with natural and artificial membranes.
Fehrenbach FJ; Eibl H
Z Naturforsch C Biosci; 1977; 32(1-2):101-9. PubMed ID: 139770
[TBL] [Abstract][Full Text] [Related]
42. R468A mutation in perfringolysin O destabilizes toxin structure and induces membrane fusion.
Kulma M; Kacprzyk-Stokowiec A; Kwiatkowska K; Traczyk G; Sobota A; Dadlez M
Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1075-1088. PubMed ID: 28263714
[TBL] [Abstract][Full Text] [Related]
43. Suicide cancer gene therapy using pore-forming toxin, streptolysin O.
Yang WS; Park SO; Yoon AR; Yoo JY; Kim MK; Yun CO; Kim CW
Mol Cancer Ther; 2006 Jun; 5(6):1610-9. PubMed ID: 16818521
[TBL] [Abstract][Full Text] [Related]
44. Kinetics of streptolysin O self-assembly.
Palmer M; Valeva A; Kehoe M; Bhakdi S
Eur J Biochem; 1995 Jul; 231(2):388-95. PubMed ID: 7635150
[TBL] [Abstract][Full Text] [Related]
45. Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O.
Hugo F; Reichwein J; Arvand M; Krämer S; Bhakdi S
Infect Immun; 1986 Dec; 54(3):641-5. PubMed ID: 3781620
[TBL] [Abstract][Full Text] [Related]
46. Oligomerization and hemolytic properties of the C-terminal domain of pyolysin, a cholesterol-dependent cytolysin.
Pokrajac L; Harris JR; Sarraf N; Palmer M
Biochem Cell Biol; 2013 Apr; 91(2):59-66. PubMed ID: 23527633
[TBL] [Abstract][Full Text] [Related]
47. Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.
Tomoyasu T; Tabata A; Hiroshima R; Imaki H; Masuda S; Whiley RA; Aduse-Opoku J; Kikuchi K; Hiramatsu K; Nagamune H
Infect Immun; 2010 Sep; 78(9):4012-21. PubMed ID: 20624907
[TBL] [Abstract][Full Text] [Related]
48. All major cholesterol-dependent cytolysins use glycans as cellular receptors.
Shewell LK; Day CJ; Jen FE; Haselhorst T; Atack JM; Reijneveld JF; Everest-Dass A; James DBA; Boguslawski KM; Brouwer S; Gillen CM; Luo Z; Kobe B; Nizet V; von Itzstein M; Walker MJ; Paton AW; Paton JC; Torres VJ; Jennings MP
Sci Adv; 2020 May; 6(21):eaaz4926. PubMed ID: 32494740
[TBL] [Abstract][Full Text] [Related]
49. Conformational changes that effect oligomerization and initiate pore formation are triggered throughout perfringolysin O upon binding to cholesterol.
Heuck AP; Savva CG; Holzenburg A; Johnson AE
J Biol Chem; 2007 Aug; 282(31):22629-37. PubMed ID: 17553799
[TBL] [Abstract][Full Text] [Related]
50. Rapid screening method for detecting highly pathogenic Streptococcus intermedius strains carrying a mutation in the lacR gene.
Tomoyasu T; Matoba M; Takao A; Tabata A; Whiley RA; Maeda N; Nagamune H
FEMS Microbiol Lett; 2018 Feb; 365(3):. PubMed ID: 29228148
[TBL] [Abstract][Full Text] [Related]
51. Electron microscopic evaluation of a two-step theory of pore formation by streptolysin O.
Sekiya K; Danbara H; Yase K; Futaesaku Y
J Bacteriol; 1996 Dec; 178(23):6998-7002. PubMed ID: 8955326
[TBL] [Abstract][Full Text] [Related]
52. Structural elements of the cholesterol-dependent cytolysins that are responsible for their cholesterol-sensitive membrane interactions.
Soltani CE; Hotze EM; Johnson AE; Tweten RK
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20226-31. PubMed ID: 18077338
[TBL] [Abstract][Full Text] [Related]
53. LuxS and expression of virulence factors in Streptococcus intermedius.
Pecharki D; Petersen FC; Scheie AA
Oral Microbiol Immunol; 2008 Feb; 23(1):79-83. PubMed ID: 18173802
[TBL] [Abstract][Full Text] [Related]
54. Mechanism of membrane damage by streptolysin-O.
Bhakdi S; Tranum-Jensen J; Sziegoleit A
Infect Immun; 1985 Jan; 47(1):52-60. PubMed ID: 3880730
[TBL] [Abstract][Full Text] [Related]
55. Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction.
Duncan JL; Schlegel R
J Cell Biol; 1975 Oct; 67(1):160-74. PubMed ID: 1176529
[TBL] [Abstract][Full Text] [Related]
56. Characterization of pneumolysin from Streptococcus pneumoniae, interacting with carbohydrate moiety and cholesterol as a component of cell membrane.
Lim JE; Park SA; Bong SM; Chi YM; Lee KS
Biochem Biophys Res Commun; 2013 Jan; 430(2):659-63. PubMed ID: 23211600
[TBL] [Abstract][Full Text] [Related]
57. Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.
Drabavicius G; Daelemans D
PLoS Genet; 2021 Feb; 17(2):e1009387. PubMed ID: 33577603
[TBL] [Abstract][Full Text] [Related]
58. β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection.
Li H; Zhao X; Wang J; Dong Y; Meng S; Li R; Niu X; Deng X
Sci Rep; 2015 Dec; 5():17668. PubMed ID: 26631364
[TBL] [Abstract][Full Text] [Related]
59. Characterization and pathogenicity of fibronectin binding protein FbpI of Streptococcus intermedius.
Kodama Y; Shimoyama Y; Ishikawa T; Kimura S; Sasaki M
Arch Microbiol; 2020 Oct; 202(8):2071-2081. PubMed ID: 32488560
[TBL] [Abstract][Full Text] [Related]
60. [Molecular mechanism of membrane pore formation with cholesterol binding cytolysin: streptolysin O and perfringolysin O].
Shimizu T; Hayashi H
Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):532-9. PubMed ID: 11268657
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
